Expression of pSmad3L and PAI-1 during the process of DEN-induced hepatic fibrosis-carcinoma in rats

Chinese Pharmacological Bulletin

Volumn 28, Issue 10, 2012, Pages 1393-1397

  Rui, Wen Juan ^a   He, Shu Fang ^a   Huang, Xian Jia ^a   Fang, Zheng ^a   Hang, Xin ^a   Li, Qian Jin ^a   Hu, Min ^a   Yang, Yan ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Diethylinitrosamine; Hepatic fibrosis; Hepatocarcinoma; Immunohistochemistry; Plasminogen activator inhibitor 1 (PAI 1); Western blot

Indexed keywords

COLLAGEN FIBER; ETHYLMETHYLNITROSAMINE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SMAD3 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL VOLUME; CONTROLLED STUDY; FATTY LIVER; HEPATOMA CELL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER NECROSIS; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

EID: 84871594613     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1001-1978.2012.10.015     Document Type: Article

References (15)

1. Yuan L P, Chen F H, Lu L, et al. Effect of TFB on TGF-β1, signaling pathway in HSC of liver fibrosis rats[J]. Chin Pharmacol Bull, 2009,25(12):1655-9.
2. Massagué J. TGFβ in cancer[J]. Cell,2008,134(2):215-30.
3. Matsuzaki K, Kitano C, Murata M, et al. Smad2 and Smad3 phosphorylated at both linker and COOH-terrainal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer[J]. Cancer Res,2009,69(13):5321-30.
4. Lian J Y, Wang Y M, Fang J, et al. The effect of transforming growth factor β1 on the proliferation and Smad proteins phosphorylation in rat myfibroblast[J]. Acta Univ Med Anhui,2006,41(5):499-502.
5. Liu X, Yang Y, Zhang X. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell invasion by modulating transforming growth factor-beta/Smad in HepG2 cell[J]. J Gastroenterol Hepatol,2010,25(2):420-6.
6. Chen Y A, Yuan L C, Dang S S, et al. Reserch of hepatocarcinogenesis model induced by low doses of DEN interruptedly[J]. Chin J Cancer Prev Treat,2005,12(11):806-8.
7. Dang S S, Cui X. Effects of saikosaponins-d on expression of C-myc and PCNA in experimental hepatocarcinoma of rats[J]. Chin Remed Clin,2009,9(7):557- 9.
8. He S, Liu X, Yang Y, et al. Mechanisms of transforming growth factor beta/Smad signalling mediated by mitogen-activated protein kinase pathways in keloidfibroblasts[J]. Br J Dermatol,2010,162:538-46.
9. Qian Y, Ling C Q. Preventive effect of Ganfujian granule on experimental hepatocarcinoma in rats[J]. World J Gastroenterol,2004,10(5):755-7. (Pubitemid 38351553)
10. Achyut B R, Yang L T. Transforming growth factor-β in the gastrointestinal and hepatic tumor microenvironment[J]. Gastroenterology,2011, 141(4):1167-78.
11. Yoshida K, Matsuzaki K, Mori S, et al. Transforming growth factor-beta and platelet-derived growth factor signal via c-Jun N-terminal kinase-dependent Smad2/3 phosphorylation in rat hepatic stellate cells after acute liver injury[J]. Am J Pathol,2005,166(4):1029-39. (Pubitemid 40524428)
12. Urukawa F, Matsuzaki K, Mori S, et al. p38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts[J]. Hepatology,2003,38(4):879-89. (Pubitemid 37221671)
13. Yuan L C, Dang S S, Cheng Y A. Targeted therapy of liver cancer[J]. Chin J Clin Pract,2003,2(12):1079-85.
14. Matsuzaki K. Smad3 phosphoisoform-mediated signaling during sporadic human colorectal carcinogenesis[J]. Histol Histopathol,2006,21(6):645-62.
15. Zheng Q, Tang Z Y, Xue Q, et al. Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor[J]. Cancer Res Clin Oncol,2000,126(11):641-6.